Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram)

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15310%2F12%3A33141331" target="_blank" >RIV/61989592:15310/12:33141331 - isvavai.cz</a>
Result on the web
<a href="http://www.sciencedirect.com/science/article/pii/S1359644611004375" target="_blank" >http://www.sciencedirect.com/science/article/pii/S1359644611004375</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.drudis.2011.12.010" target="_blank" >10.1016/j.drudis.2011.12.010</a>

Result language
angličtina
Original language name
Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram)
Original language description
The effort to repurpose old drugs for new uses is not sufficient; even drugs that have been used clinically for decades must undergo expensive clinical trials. This process requires the pharmaceutical industry to fund the repatenting of old drugs. Because inexpensive drugs are necessary for people around the world, attempts should be made to develop nonprofit drugs through clinical trials of generic drugs that are funded by governments and charities. Evidence supports the use the old anti-alcoholic drugAntabuse as a new nonprofit drug for cancer.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FR - Pharmacology and apothecary chemistry
OECD FORD branch
—

Project
<a href="/en/project/EE.2.3.20.0062" target="_blank" >EE.2.3.20.0062: An inexpensive drug Antabuse as anticancer remedy: mechanism of action and clinical trials</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)